Conexeu Sciences Inc. CNXU
NASDAQ
| 07/31/2026 | 04/30/2026 | 01/31/2026 | 10/31/2025 | ||
|---|---|---|---|---|---|
| Net Income | -494.93% | -403.01% | -492.49% | -1,620.35% | |
| Total Depreciation and Amortization | 131.82% | 235.29% | 966.67% | -- | |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | |
| Total Other Non-Cash Items | 408.64% | 18,200.00% | 282.83% | 1,228.37% | |
| Change in Net Operating Assets | -3,703.56% | 556.52% | -426.83% | 112.31% | |
| Cash from Operations | -1,077.94% | -320.69% | -551.29% | -182.83% | |
| Capital Expenditure | -10,250.00% | -527.08% | 65.19% | -- | |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | 100.00% | -- | -- | -- | |
| Cash from Investing | -1.47% | -527.08% | 65.19% | -- | |
| Total Debt Issued | -- | -- | -- | -- | |
| Total Debt Repaid | -2,464.10% | -- | -- | -- | |
| Issuance of Common Stock | -99.91% | -- | 446.51% | 2,268.55% | |
| Repurchase of Common Stock | -- | -- | -- | -- | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | 1,903.11% | -- | -- | -- | |
| Cash from Financing | 24.21% | 2,472.34% | 521.11% | 2,299.46% | |
| Foreign Exchange rate Adjustments | 168.18% | -- | -- | -92.65% | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | -775.65% | 211.28% | 529.83% | 9,852.74% | |